House Concurrent Resolution No. by Representative Moore urges the United States Food and Drug Administration (FDA) to regulate tattoo ink, highlighting the significant prevalence of tattoos among Americans and the associated health risks. With approximately one-third of the population having tattoos and a notable portion expressing regret over their decisions, the resolution points to the potential dangers linked to tattoo inks, including bacterial infections, allergic reactions, and possible connections to skin cancer. It references recent findings from researchers indicating that certain color additives in tattoo inks may convert to carcinogens under specific conditions.

The resolution emphasizes that while the FDA has the authority to regulate materials that come into contact with skin, it has yet to implement any binding regulations or enforcement actions regarding tattoo ink, despite the health risks involved. It calls for the FDA to take action to ensure the safety of color additives used in tattoo inks, thereby promoting the health and safety of U.S. citizens. A copy of the resolution is to be sent to the FDA commissioner to advocate for this regulatory change.